297 related articles for article (PubMed ID: 19527113)
21. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
McCarron PA; Marouf WM; Donnelly RF; Scott C
J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
[TBL] [Abstract][Full Text] [Related]
22. Transferrin-conjugated nanoparticles of poly(lactide)-D-alpha-tocopheryl polyethylene glycol succinate diblock copolymer for targeted drug delivery across the blood-brain barrier.
Gan CW; Feng SS
Biomaterials; 2010 Oct; 31(30):7748-57. PubMed ID: 20673685
[TBL] [Abstract][Full Text] [Related]
23. Brain targeting and toxicity study of odorranalectin-conjugated nanoparticles following intranasal administration.
Wen Z; Yan Z; He R; Pang Z; Guo L; Qian Y; Jiang X; Fang L
Drug Deliv; 2011 Nov; 18(8):555-61. PubMed ID: 21812752
[TBL] [Abstract][Full Text] [Related]
24. Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations.
Chen J; Zhang C; Liu Q; Shao X; Feng C; Shen Y; Zhang Q; Jiang X
J Drug Target; 2012 Feb; 20(2):174-84. PubMed ID: 21992548
[TBL] [Abstract][Full Text] [Related]
25. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
[TBL] [Abstract][Full Text] [Related]
26. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery.
Mei H; Shi W; Pang Z; Wang H; Lu W; Jiang X; Deng J; Guo T; Hu Y
Biomaterials; 2010 Jul; 31(21):5619-26. PubMed ID: 20413154
[TBL] [Abstract][Full Text] [Related]
27. Aclarubicin-loaded cationic albumin-conjugated pegylated nanoparticle for glioma chemotherapy in rats.
Lu W; Wan J; Zhang Q; She Z; Jiang X
Int J Cancer; 2007 Jan; 120(2):420-31. PubMed ID: 17066446
[TBL] [Abstract][Full Text] [Related]
28. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
[TBL] [Abstract][Full Text] [Related]
29. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
[TBL] [Abstract][Full Text] [Related]
30. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution.
Tosi G; Vergoni AV; Ruozi B; Bondioli L; Badiali L; Rivasi F; Costantino L; Forni F; Vandelli MA
J Control Release; 2010 Jul; 145(1):49-57. PubMed ID: 20338201
[TBL] [Abstract][Full Text] [Related]
31. Nanoparticles of poly(lactide)-tocopheryl polyethylene glycol succinate (PLA-TPGS) copolymers for protein drug delivery.
Lee SH; Zhang Z; Feng SS
Biomaterials; 2007 Apr; 28(11):2041-50. PubMed ID: 17250886
[TBL] [Abstract][Full Text] [Related]
32. The brain targeting mechanism of Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles.
Xin H; Sha X; Jiang X; Chen L; Law K; Gu J; Chen Y; Wang X; Fang X
Biomaterials; 2012 Feb; 33(5):1673-81. PubMed ID: 22133551
[TBL] [Abstract][Full Text] [Related]
33. Body distribution and in situ evading of phagocytic uptake by macrophages of long-circulating poly (ethylene glycol) cyanoacrylate-co-n-hexadecyl cyanoacrylate nanoparticles.
Huang M; Wu W; Qian J; Wan DJ; Wei XL; Zhu JH
Acta Pharmacol Sin; 2005 Dec; 26(12):1512-8. PubMed ID: 16297352
[TBL] [Abstract][Full Text] [Related]
34. Coupling of biotin-(poly(ethylene glycol))amine to poly(D,L-lactide-co-glycolide) nanoparticles for versatile surface modification.
Weiss B; Schneider M; Muys L; Taetz S; Neumann D; Schaefer UF; Lehr CM
Bioconjug Chem; 2007; 18(4):1087-94. PubMed ID: 17590034
[TBL] [Abstract][Full Text] [Related]
35. Translocation of poly(ethylene glycol-co-hexadecyl)cyanoacrylate nanoparticles into rat brain endothelial cells: role of apolipoproteins in receptor-mediated endocytosis.
Kim HR; Andrieux K; Gil S; Taverna M; Chacun H; Desmaële D; Taran F; Georgin D; Couvreur P
Biomacromolecules; 2007 Mar; 8(3):793-9. PubMed ID: 17309294
[TBL] [Abstract][Full Text] [Related]
36. Brain targeting of Atorvastatin loaded amphiphilic PLGA-b-PEG nanoparticles.
Simşek S; Eroğlu H; Kurum B; Ulubayram K
J Microencapsul; 2013; 30(1):10-20. PubMed ID: 22734433
[TBL] [Abstract][Full Text] [Related]
37. Lectin-conjugated PEG-PLA nanoparticles: preparation and brain delivery after intranasal administration.
Gao X; Tao W; Lu W; Zhang Q; Zhang Y; Jiang X; Fu S
Biomaterials; 2006 Jun; 27(18):3482-90. PubMed ID: 16510178
[TBL] [Abstract][Full Text] [Related]
38. Polymeric nanoparticles for drug delivery.
Chan JM; Valencia PM; Zhang L; Langer R; Farokhzad OC
Methods Mol Biol; 2010; 624():163-75. PubMed ID: 20217595
[TBL] [Abstract][Full Text] [Related]
39. Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.
Han J; Wang Q; Zhang Z; Gong T; Sun X
Small; 2014 Feb; 10(3):524-35. PubMed ID: 24106138
[TBL] [Abstract][Full Text] [Related]
40. Lactoferrin-modified PEG-co-PCL nanoparticles for enhanced brain delivery of NAP peptide following intranasal administration.
Liu Z; Jiang M; Kang T; Miao D; Gu G; Song Q; Yao L; Hu Q; Tu Y; Pang Z; Chen H; Jiang X; Gao X; Chen J
Biomaterials; 2013 May; 34(15):3870-81. PubMed ID: 23453061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]